Women's health study signs up millionth woman

Kmietowicz, Zosia
October 2000
BMJ: British Medical Journal (International Edition);10/21/2000, Vol. 321 Issue 7267, p981
Academic Journal
Reports on the willingness of more than one million volunteers to take part in a study of women's health in Great Britain. Details of the study, which will address the risk of breast cancer associated with hormone replacement therapy (HRT) in aging women; Impact of HRT and other factors on heart disease, bone disease, and joint replacement in women; Other women's health issues included in the study; Outlook for the study's results.


Related Articles

  • WHI now reports higher risk of breast cancer mortality from combined HRT use. Brown, Simon // Menopause International;Dec2010, Vol. 16 Issue 4, p136 

    The article reports on a study from the Women's Health Initiative which found that combined hormone replacement therapy (HRT) is associated with increased breast cancer risk and could interfere with breast cancer detection, leading to cancers being diagnosed at late stages. WHI investigators...

  • Soy intake and breast cancer risk in Singapore Chinese Health Study. Wu, A. H.; Koh, W.-P.; Wang, R.; Lee, H.-P.; Yu, M. C. // British Journal of Cancer;7/8/2008, Vol. 99 Issue 1, p196 

    We investigated the effects of soy isoflavone intake on breast cancer in a prospective study of 35 303 Singapore Chinese women enrolled during April 1993 to December 1998 in the Singapore Chinese Health Study. At recruitment, each subject was personally administered a validated semiquantitative...

  • Hormonal balance. Fricker, Janet // Nursing Standard;3/31/2004, Vol. 18 Issue 29, p18 

    Discusses the negative publicity affecting the viability of hormone replacement therapy (HRT). Adverse reactions attributed to HRT; High risk of breast cancer associated with HRT; Problems with HRT prescribing; Role played by nurse prescribing in HRT.

  • Risk of breast cancer associated with hormone replacement therapy. Dopp, J.M.; Kolesar, J.M. // Journal of Oncology Pharmacy Practice;Sep1999, Vol. 5 Issue 3, p109 

    Purpose. The primary objective of this paper is to provide a brief overview of the risk of breast cancer associated with hormone replacement therapy (HRT) in healthy postmenopausal women, in breast cancer survivors, and in women at increased risk for breast cancer. Data Sources. The literature...

  • The HRT Dilemma. Kotz, Deborah // U.S. News & World Report;10/29/2007, Vol. 143 Issue 15, p50 

    The article weighs the benefits and drawbacks of hormone replacement therapy (HRT) for women. A 2002 report linked the use of HRT to increases in incidents of breast cancer, heart disease, and stroke in postmenopausal women. The report led to a 75 percent reduction in HRT utilization. More...

  • Antibiotics may raise risk of breast cancer.  // Pulse;2/23/2004, Vol. 64 Issue 8, p24 

    Reports on the finding by U.S. researchers that the long-term use of antibiotics by women may be linked to an increased risk of breast cancer. Risk for women with more than 25 prescriptions for antibiotics over an average of 17 years; Adjustment of data for users of postmenopausal hormones.

  • Bone mineral density at menopause does not predict breast cancer incidence. TrĂ©mollieres, F. A.; Pouillès, J.-M.; Laparra, J.; Ribot, C. // Osteoporosis International;Oct2008, Vol. 19 Issue 10, p1497 

    In this prospective study in 2,137 perimenopausal and early postmenopausal women who were followed over a 13.1-year period of time, we observed no association between bone mineral density measured at the beginning of menopause and the subsequent risk of breast cancer. This study aimed to...

  • red-hot HORMONE UPDATE. Lloyd, Joanna // Prevention;Apr2007, Vol. 59 Issue 4, p158 

    The article presents an overview of information on hormone therapy for symptoms of menopause. A 2002 study by the World Health Organization found increased risks of breast cancer and heart disease for long-term users of estrogen, but short-term use of up to five years does not seem to do the...

  • HRT: another trial halted after breast cancer link.  // PharmaWatch: Cancer;March 2004, Vol. 3 Issue 3, p16 

    Reports on the discontinuation of the HABITS study, a trial which investigated the safety of hormone replacement therapy (HRT) among breast cancer survivors, when data showed that HRT users faced a higher risk of breast cancer recurrence. Findings reported by the journal "Lancet," from a HRT...


Read the Article


Sign out of this library

Other Topics